The
CIRM and CIRM faculty are currently conducting several clinical trials
evaluating stem cell therapy for treatment of diseases of dogs and cats. These trials are supported by several
non-profit organizations, including the Shipley Foundation, the Eldred
Foundation, and the Canine Health Foundation. Eligibility for each trial will be determined by trial coordinators, and
for the studies listed below, treatment must be received at the CSU Veterinary
Teaching Hospital. Typically clinical
trials will pay a portion of or in some cases all the costs associated with the
stem cell treatment.
Eligibility: Dogs with chronic (> 2 weeks duration) bacterial infections with known drug-resistant bacterial pathogens are eligible for entry into a funded clinical trial to evaluate the effectiveness of activated MSC therapy.
Contact:
Dr. Valerie Johnson (Valerie.Johnson@colostate.edu)
Dr. Steven Dow (Steven.Dow@colostate.edu)
Stem cell therapy for canine wound healing
Eligibility: Dogs eligible for this study will have large
cutaneous wounds that cannot be managed by simple suturing, and typically
require multiple bandage changes weekly. Infected cutaneous wounds are also eligible. The study will evaluate the effectiveness of
mesenchymal stem cells (obtained from young donor dogs) imbedded in a
biological matrix for stimulation of more rapid wound healing and infection
control. Eligible patients must be in
good overall health, and not be receiving concurrent immune suppressive or
immune modulatory therapy. The study
will involve twice weekly topical treatments with stem cells in matrix
material, and costs of stem cell treatment are covered by the study.
Contact:
Dr. Valerie Johnson (Valerie.Johnson@colostate.edu)
Dr. Steven Dow (Steven.Dow@colostate.edu)